Uncategorized Archives - PulmCCM
Advertisement


Uncategorized Articles

Aug 312016
 
Anemia & the Injured Brain

“We do not live in a privileged frame of reference.” -Carl Sagan It is a common human experience to feel that one is the exception.  Indeed, the study of cosmology has demoted our – once privileged – place in the cosmos.  We have fallen from the center of the universe to inhabiting but one planet [… read more]

Jun 102016
 
Call for Abstracts: Pittsburgh-Munich International Lung Conference

Have you submitted your abstract to the 2016 Pittsburgh – Munich International Lung Conference? Concurrent submissions are accepted!  Use the abstracts you have submitted this spring for other national/international conferences (i.e. ATS) for a chance to further showcase your work.  Click on the links below to begin. The 2016 Pittsburgh – Munich International Lung Conference [… read more]

May 012016
 
ICU Physiology in 1,000 Words: ARDS - Part 2

Jon-Emile S. Kenny [@heart_lung] Gattinoni and Quintel have, very recently, outlined their approach to managing the acute respiratory distress syndrome [ARDS] [1].  They argue that treatment of ARDS should minimize firstly, the mechanical power applied to the lungs – as described in part 1.  Secondly, Gattinoni and Quintel note that, in the treatment of ARDS, [… read more]

Jun 252015
 
PulmCCM Journal Vol. 1, Issue 3 Now Available

Issue #3 of PulmCCM Journal, an open-access, peer-reviewed journal in pulmonary and critical care medicine, is now available online. Click the link, or the “Journal” tab in the menu bar on PulmCCM to read the latest issue of PulmCCM Journal. This issue’s featured concise clinical review is “Who should undergo intracranial pressure monitoring in acute liver failure?” by [… read more]

Apr 032014
 
FDA warns against doripenem (Doribax) for ventilator-associated pneumonia

FDA Warning on Doripenem (Doribax) for VAP In March 2014, the FDA issued a warning statement against Doribax (doripenem) for ventilator associated pneumonia, saying: Doribax carries an increased risk of death and lower clinical cure rates compared to use of imipenem and cilastatin … Doribax is not approved to treat any type of pneumonia. (Doripenem is approved [… read more]

Mar 252014
 

May 10th and 11th (pre-congress courses on may 9th), Montreal. Great speakers, great topics, great city, great weather (well…hopefully no snow!). Do you know how to use ultrasound to help you diagnose or manage coma, bowel obstruction, CHF, dyspnea, swollen joints and renal failure, among other things?  No matter how good you are at the [… read more]

Sep 122013
 
Join Us at the 2013 Pittsburgh International Lung Conference

We are quickly approaching the 2013 Pittsburgh International Lung Conference on October 17-18, 2013. The theme, “Acute and Chronic Lung Infections: Novel Pathogens, Diagnostics, and Therapeutics aims to describe and discuss the latest clinical and research advances as they apply to respiratory infections by bringing together leading regional, national, and international experts in the field. [… read more]

Sep 052013
 

Following “Surviving Sepsis” Guidelines Not Always the Best Care By Dr. Philippe Rola First of all, I would like to commend those involved in the Surviving Sepsis Campaign’s Guidelines. It is a tremendous endeavour that, without a doubt, has heightened awareness and their growing implementation has and will save many lives. I would, however, also [… read more]

Jun 152013
 
Thanks to everyone for your help.

The PulmCCM “Wall of Fame” THANKS to all of you who supported PulmCCM during the successful campaign to raise funding for development of high-quality iPhone and Android mobile apps. I really appreciate each and every one of your help (in chronological order): Anonymous Manish Aggarwal Lewis Satterwhite Robert Deutsch Mehdi Shelhamer Manuel Figueroa Mark Bloore [… read more]

Mar 312013
 
A New Way to Share: PulmCCM on Doximity

PulmCCM Debuts the New “Doximity Button” Are you on Doximity yet? It’s the brainchild of Internet health-tech visionary Nate Gross and the founders of Epocrates. It’s been called “Facebook for doctors,” but Doximity is more than that. It’s a protected, HIPAA-compliant online environment for physicians to communicate securely, and has the potential to change how we [… read more]

Sep 022012
 

Definition of Severe Sepsis by the Surviving Sepsis Guidelines Severe sepsis is sepsis (known or suspected infection with systemic manifestations of sepsis) along with sepsis-related tissue hypoperfusion or organ dysfunction. Organ dysfunction or tissue hypoperfusion are defined by the Surviving Sepsis Campaign as any of the below signs or findings: Signs of Severe Sepsis: Organ [… read more]